Literature DB >> 29341357

A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan.

Nobuaki Nakayama1, Hayato Uemura1, Yoshihito Uchida1, Tomoaki Tomiya1, Akio Ido2, Kazuaki Inoue3, Takuya Genda4, Yasuhiro Takikawa5, Isao Sakaida6, Shuji Terai7, Osamu Yokosuka8, Masahito Shimizu9, Hajime Takikawa10, Satoshi Mochida1.   

Abstract

AIM: To establish diagnostic criteria for acute-on-chronic liver failure (ACLF) in Japan, a multicenter pilot survey was carried out to examine the usefulness of overseas criteria in patients with chronic liver diseases manifesting acute decompensation.
METHODS: Patients fulfilling the Asian-Pacific Association for the Study of the Liver (APASL), European Association for the Study of the Liver (EASL), or Chinese Medical Association (CMA) criteria for decompensation were enrolled from eight institutions in Japan, and the clinical features were evaluated.
RESULTS: Among 112 patients, 109 patients (97.3%) fulfilled the APASL criteria for decompensation; 7 patients were excluded because the decompensation had been provoked by gastrointestinal bleeding. Consequently, 102 patients (91.1%) were diagnosed as having ACLF according to the APASL definition. Among the patients who fulfilled the APASL criteria for decompensation, the etiologies of the underlying liver diseases were alcohol abuse in 59 cases (54.1%) and hepatitis B or hepatitis C virus infection in 24 (22.0%). The acute insults were alcohol abuse in 50 (45.9%), bacterial infection in 26 (23.9%), and exacerbation of underlying liver disease in 14 (12.8%). Fifty-four patients (49.5%) satisfied the CMA criteria, but the survival rates were similar between patients who did and those who did not meet the criteria. When 84 patients with underlying cirrhosis were classified according to the EASL-Chronic Liver Failure (Clif) Consortium criteria, the survival rates differed according to grade: 67.6% (23/34) for patients without ACLF, and 41.2% (14/34) and 18.8% (3/16) for those with grade 1/2 and grade 3 ACLF, respectively.
CONCLUSION: The APASL definition was suitable for screening Japanese patients with ACLF, including those whose conditions were triggered by gastrointestinal bleeding, and the EASL-Clif Consortium criteria were useful for predicting outcome.
© 2018 The Japan Society of Hepatology.

Entities:  

Keywords:  ACLF; APASL; CMA; EASL; acute-on-chronic liver failure

Year:  2018        PMID: 29341357     DOI: 10.1111/hepr.13064

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

1.  Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure.

Authors:  Meng Zhang; Xin Xu; Wei Liu; Zhongwei Zhang; Qiuyu Cheng; Zhongyuan Yang; Tingting Liu; Yunhui Liu; Qin Ning; Tao Chen; Junying Qi
Journal:  Adv Ther       Date:  2021-07-25       Impact factor: 3.845

2.  Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Shinya Sato; Kosuke Kaji; Yuki Tsuji; Daisuke Kaya; Yukihisa Fujinaga; Yasuhiko Sawada; Naotaka Shimozato; Hideto Kawaratani; Kei Moriya; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

3.  Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.

Authors:  Hitomi Hoshi; Po-Sung Chu; Aya Yoshida; Nobuhito Taniki; Rei Morikawa; Karin Yamataka; Fumie Noguchi; Ryosuke Kasuga; Takaya Tabuchi; Hirotoshi Ebinuma; Hidetsugu Saito; Takanori Kanai; Nobuhiro Nakamoto
Journal:  PLoS One       Date:  2021-04-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.